Alexandria Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-74
Closed -$11K 521
2017
Q3
$11K Buy
74
+4
+6% +$602 ﹤0.01% 411
2017
Q2
$9K Buy
70
+9
+15% +$1.08K ﹤0.01% 438
2017
Q1
$7K Buy
61
+5
+9% +$440 ﹤0.01% 463
2016
Q4
$4K Buy
56
+9
+19% +$732 ﹤0.01% 503
2016
Q3
$4K Buy
47
+7
+18% +$662 ﹤0.01% 516
2016
Q2
$3K Buy
40
+6
+18% +$518 ﹤0.01% 534
2016
Q1
$3K Buy
34
+18
+113% +$1.63K ﹤0.01% 540
2015
Q4
$2K Buy
+16
New +$1.93K ﹤0.01% 604
2014
Q3
Sell
-29
Closed -$3K 596
2014
Q2
$3K Sell
29
-21
-42% -$1.47K ﹤0.01% 511
2014
Q1
$4K Hold
50
﹤0.01% 489
2013
Q4
$4K Sell
50
-27
-35% -$1.88K ﹤0.01% 500
2013
Q3
$6K Buy
77
+7
+10% +$557 ﹤0.01% 437
2013
Q2
$6K Buy
+70
New +$5.16K ﹤0.01% 460

Other funds holding VRTX